Myeloproliferative Disorders
Symptoms, Risk Factors and Treatment Options
Seiten
2014
Nova Science Publishers Inc (Verlag)
978-1-63321-201-5 (ISBN)
Nova Science Publishers Inc (Verlag)
978-1-63321-201-5 (ISBN)
Myeloproliferative disorders are a group of clonal haematological neoplasms characterised by proliferation of one or more cells of myeloid lineage. They are the result of acquired mutations in the progenitor cell leading to hyper proliferation or neoplastic expansion of more mature forms of myeloid cells. Cells retain their functional ability with some degree of defects and also lead to suppression of normal stem cells. The most common type of Myeloproliferative Neoplasms (MPN) can broadly be classified into BCR ABL positive (Chronic Myelogenous Leukemia) and BCR ABL negative Disorders (Polycythemia Vera PV, Essential Thrombocytosis ET and Primary Myelofibrosis PMF). There are other rare types which have relatively low incidence like chronic neutrophilic leukemia, chronic eosinophilic leukemia, systemic mastocytosis and myeloproliferative neoplasms unclassifiable. These are the indolent type of haematological malignancies associated with marrow hypercellularity and organomegaly, with gradual progression to myelofibrosis or transformation to acute leukemias. During the dormant course of the BCR ABL negative MPN, they are more prone to thrombo-hemorrhagic complications and the treatment strategy is directed mostly to prevent complications. The past decade; therapies for BCR ABL positive disease (CML) have been a milestone achievement in keeping the disease in remission for many years, preventing major complications and halting the progression of the disease. This book discusses the classification, diagnosis and treatment of myeloproliferative diseases and provides insight on the symptoms and risk factors involved in the diseases.
PrefaceMyeloproliferative Diseases: Classification, Diagnosis and Treatment(Farhan Mohammad, FNU Vikram, Wajeeha Saeed, George Everett, Amr Lal, Muhammad Rizwan Sardar, Staten Island University Hospital, Staten Island, NY, USA, and others)Histopathology and Diagnostic Approaches to the Myeloproliferative Neoplasms(Christina Salazar, Sanjeev M. Balamohan, Patrick D. Millikan, Wendy H. Raskind, Melissa A. Kacena, Indiana University School of Medicine, Indianapolis, IN, USA, and others)For Complete Table of Contents, please visit our website athttps://www.novapublishers.com/catalog/product_info.php?products_id=50211
Erscheint lt. Verlag | 1.9.2014 |
---|---|
Verlagsort | New York |
Sprache | englisch |
Maße | 152 x 229 mm |
Gewicht | 236 g |
Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Hämatologie |
ISBN-10 | 1-63321-201-7 / 1633212017 |
ISBN-13 | 978-1-63321-201-5 / 9781633212015 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Hämatologie und Internistische Onkologie
Buch | Softcover (2023)
ecomed-Storck GmbH (Verlag)
CHF 179,95
Buch | Softcover (2024)
Urban & Fischer in Elsevier (Verlag)
CHF 73,00